Daniel Virnich - 21 May 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Executive Officer
Signature
By: Mark Hueppelsheuser, Attorney-in-Fact For: Daniel Virnich
Issuer symbol
TOI
Transactions as of
21 May 2024
Net transactions value
-$6,673
Form type
4
Filing time
23 May 2024, 18:33:50 UTC
Previous filing
22 Nov 2023
Next filing
18 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Disposed to Issuer $6,673 -11,173 -1.5% $0.5972 718,430 21 May 2024 Direct F1
transaction TOI Common Stock Award $0 +198,517 +28% $0.000000 916,947 21 May 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Non-Qualified Stock Option (right to buy) Award $0 +496,293 $0.000000 496,293 21 May 2024 Common Stock 496,293 $2.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
F2 Represents RSUs with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
F3 The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.